Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 10-nov-2026 · last seen 10-nov-2026

Cannabigerol (CBG)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-30 — Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.: [animal-model] A four-week study in mice with dexamethasone-induced muscle atrophy reported that CBG (10 mg/kg intraperitoneally on training days) combined with resistance exercise improved muscle power output, peak grip strength, and lactate clearance; these findings do not establish benefits in humans or age-related sarcopenia. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

pubmed preclinical animal-model
Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.
30-sep-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18